Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: July 15, 2012
A novel monthly dosing regimen of risedronate for the treatment of postmenopausal osteoporosis: 2-year data.
Journal: Calcified tissue international
Published: June 29, 2012
Showing 1-2 of 2
Last Updated: 09/26/2026